LAS VEGAS -- Event-free survival (EFS) in high-risk non-muscle invasive bladder cancer (NMIBC) improved significantly when ...

A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

Elderly colon cancer patients are being given the chance to access a clinical trial led by the University of Leeds that could ...

Despite the massive successes of immunotherapy, which utilizes the body’s immune system as a tool to fight cancer, therapy ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...